whatshot

CLYM   $6.98  -1.97% Market Closed After Close 6.98 0.0

Climb Bio, Inc.
show_chart Advanced Chart of CLYM

Current temperature: 0.00
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 9
Target Price Mean 14.00
Mean unverified/preliminary 14.00 / 14.00
Target Price Low / High 8.00 / 25.00
Median / STD DEV 12.00 / 6.12
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy Buy ActivelyBuy
rsi ActivelyBuy Buy None
macd None None None
stoch None None None
ma20 Sell Sell Sell
ma50 None None None
ma100 None Buy ActivelyBuy
Candlestick PatternMarch 16, 2026 Bullish Harami - consists of an unusually large black body followed by a small white body contained within large black body. It is considered as a bullish pattern when preceded by a downtrend.
ISIN US28658R1068
ceo Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc
Website https://eliemtx.com
Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an anti-CD19 monoclonal antibody for various autoimmune diseases, including systemic lupus erythematosus and lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wilmington, Delaware.